Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling

Molecular Carcinogenesis

Volumn 53, Issue 4, 2014, Pages 286-299

  Keith, Meggan E ^a   Laporta, Erika ^a   Welsh, Joellen ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Breast cancer; Genomic; Non genomic; Vitamin D; Vitamin D analog

Indexed keywords

CALCITRIOL; SEOCALCITOL; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST TUMOR; CALCIUM HOMEOSTASIS; CELL LINE; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; FAMILIAL HYPOPHOSPHATEMIC RICKETS; FOLLOW UP; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MOUSE; NONHUMAN; NULL CELL; POINT MUTATION; PRIORITY JOURNAL; STABLE EXPRESSION; TRANSIENT TRANSFECTION; WILD TYPE;

MURINAE; MUS;

BREAST CANCER; GENOMIC; NON-GENOMIC; VITAMIN D; VITAMIN D ANALOG;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; HUMANS; MICE; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; VITAMIN D;

EID: 84895805977     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21975     Document Type: Article

References (35)

1. Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1alpha, 25(OH)vitamin D: Genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011; 25:543-559.
2. Schrader M, Kahlen J-P, Carlberg C. Functional characterization of a novel type of 1a, 25-dihydroxyvitamin D3 response element identified in the mouse c-fos promoter. Biochem Biophys Res Commun 1997; 230:646-651.
3. Thummel KE, Brimer C, Yasuda K, et al. Transcriptional control of intestinal cytochrome P-4503A by 1alpha, 25-dihydroxy vitamin D3. Mol Pharmacol 2001; 60:1399-1406.
4. Quack M, Carlberg C. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. J Mol Biol 2000; 296:743-756.
5. Xie Z, Bikle DD. Cloning of the human phospholipase C-gamma1 promoter and identification of a DR6-type vitamin D-responsive element. J Biol Chem 1997; 272:6573-6577.
6. Saramaki A, Banwell CM, Campbell MJ, Carlberg C. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 2006; 34:543-554.
7. Thompson PD, Jurutka PW, Whitfield GK, et al. Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements. Biochem Biophys Res Commun 2002; 299:730-738.
8. Danielsson C, Mathiasen IS, James SY, et al. Sensitive induction of apoptosis in breast cancer cells by a novel 1, 25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity. J Cell Biochem 1997; 66:552-562.
9. Nayeri S, Danielsson C, Kahlen JP, et al. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Oncogene 1995; 11:1853-1858.
10. 3. Oncogene 2004; 23:4856-4861.
11. Rochel N, Moras D. Ligand binding domain of vitamin D receptors. Curr Top Med Chem 2006; 6:1229-1241.
12. Capiati DA, Rossi AM, Picotto G, Benassati S, Boland RL. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha, 25(OH)2-vitamin D3 in MCF-7 breast cancer cells. J Cell Biochem 2004; 93:384-397.
13. Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha, 25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 2004; 18:2660-2671.
14. Zanello LP, Norman AW. Rapid modulation of osteoblast ion channel responses by 1alpha, 25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 2004; 101:1589-1594.
15. Ordonez-Moran P, Alvarez-Diaz S, Valle N, et al. The effects of 1, 25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling. J Steroid Biochem Mol Biol 2010; 121:355-361.
16. Hedlund TE, Moffatt KA, Miller GJ. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: Evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Endocrinology 1996; 137:1554-1561.
17. Davoust N, Wion D, Chevalier G, et al. Vitamin D receptor stable transfection restores the susceptibility to 1, 25-dihydroxyvitamin D3 cytotoxicity in a rat glioma resistant clone. J Neurosci Res 1998; 52:210-219.
18. Peng X, Jhaveri P, Hussain-Hakimjee EA, Mehta RG. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5. Carcinogenesis 2007; 28:1000-1007.
19. Zinser GM, McEleney K, Welsh J. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Mol Cell Endocrinol 2003; 200:67-80.
20. Valrance ME, Brunet AH, Welsh J. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo. Endocrinology 2007; 148:4887-4894.
21. Valrance ME, Brunet AH, Acosta A, Welsh J. Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells. J Cell Biochem 2007; 101:1505-1519.
22. Rowling MJ, Kemmis CM, Taffany DA, Welsh J. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J Nutr 2006; 136:2754-2759.
23. Valrance ME, Welsh J. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor. J Steroid Biochem Mol Biol 2004; 89-90:221-225.
24. Wang TT, Tavera-Mendoza LE, Laperriere D, et al. Large-scale in silico and microarray-based identification of direct 1, 25-dihydroxyvitamin D3 target genes. Mol Endocrinol 2005; 19:2685-2695.
25. Sun J, Kong J, Duan Y, et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006; 291:E315-E322.
26. Tse AK, Zhu GY, Wan CK, et al. 1alpha, 25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells. Mol Immunol 2010; 47:1728-1738.
27. Conley-LaComb MK, Huang W, Wang S, et al. PTEN regulates PDGF ligand switch for beta-PDGFR signaling in prostate cancer. Am J Pathol 2012; 180:1017-1027.
28. Matilainen JM, Malinen M, Turunen MM, Carlberg C, Vaisanen S. The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells. J Biol Chem 2010; 285:24174-24183.
29. Nguyen TM, Adiceam P, Kottler ML, et al. Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1, 25-dihydroxyvitamin D. J Bone Miner Res 2002; 17:1728-1737.
30. Nguyen TM, Lieberherr M, Fritsch J, et al. The rapid effects of 1, 25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: Studies in human skin fibroblasts bearing vitamin D receptor mutations. J Biol Chem 2004; 279:7591-7591.
31. Aljubeh JM, Wang J, Al-Remeithi SS, Malloy PJ, Feldman D. Report of two unrelated patients with hereditary vitamin D resistant rickets due to the same novel mutation in the vitamin D receptor. J Pediatr Endocrinol Metab 2011; 24:793-799.
32. Kristjansson K, Rut AR, Hewison M, O'Riordan JL, Hughes MR. Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1, 25 dihydroxyvitamin D3. J Clin Invest 1993; 92:12-16.
33. Carlberg C, Seuter S, Heikkinen S. The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res 2012; 32:271-282.
34. Meyer MB, Goetsch PD, Pike JW. VDR/RXR and TCF4/beta-catenin cistromes in colonic cells of colorectal tumor origin: Impact on c-FOS and c-MYC gene expression. Mol Endocrinol 2012; 26:37-51.
35. Bettoun DJ, Buck DW, Lu J, et al. A vitamin D receptor-Ser/Thr phosphatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand. J Biol Chem 2002; 277:24847-24850.